Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.

Rezasoltani, Sama; Yadegar, Abbas; Asadzadeh Aghdaei, Hamid; Reza Zali, Mohammad

Rezasoltani, Sama; Yadegar, Abbas; Asadzadeh Aghdaei, Hamid; Reza Zali, Mohammad.

Afiliação

Rezasoltani S; Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Yadegar A; Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Asadzadeh Aghdaei H; Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Reza Zali M; Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Cancer Med ; 10(3): 1141-1154, 2021 02.

Article em En | MEDLINE | ID: mdl-33369247

Assuntos

Microbioma Gastrointestinal/imunologia; Inibidores de Checkpoint Imunológico/uso terapêutico; Imunoterapia/métodos; Neoplasias/tratamento farmacológico; Animais; Homeostase; Humanos; Neoplasias/imunologia; Neoplasias/microbiologia

Palavras-chave

PD-1/PD-L1 inhibitors; cancer immunotherapy; gut microbiomarkers; gut microbiota; immune checkpoint inhibitors; oncomicrobes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal / Inibidores de Checkpoint Imunológico / Imunoterapia / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google